East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Colchicine Capsules, 0.6 mg. Aurobindo Pharma’s Colchicine Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD),Mitigare Capsules manufactured by Hikma International Pharmaceuticals LLC.

Colchicine Capsules are indicated for:

• Prophylaxis of gout flares in adults.